CAV1 and hepatocellular carcinoma: Strikingly, in contrast to our HCC cell-based models, siCAV1 #4 was more potent in downregulating CAV1 mRNA and inhibiting growth in HCC PDOs compared to siCAV1 #2 (Fig. 7I, J, M & Suppl.